Rosetta Genomics Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
Rosetta Genomics Ltd. reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum of 116.00% for the 12-month period ending 2016-12-31, per its 6-K filed 2017-10-10.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum · last filed 2017-10-10
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 12 month |
|---|---|
| 2016-12-31 | 116.00% 6-K · filed 2017-10-10 |
| 2015-12-31 | 126.00% 6-K · filed 2017-10-10 |
| 2014-12-31 | 125.00% 6-K · filed 2017-10-10 |
| 2013-12-31 | 131.00% 6-K · filed 2016-12-08 |
| 2012-12-31 | 123.00% 20-F · filed 2015-03-16 |